APO Research
Talk to an analyst

APO RESEARCH · REPORT

Prenatal Screening

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Prenatal Screening Market Analysis and Forecast 2026-2032

12 April 2026180 pages

Choose your research edition.

Industry ResearchPrenatal Screening Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Prenatal Screening Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Prenatal Screening Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Prenatal Screening Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Prenatal Screening Market Analysis and Forecast 2026-2032180 pages · $4,950 USD

Market perspective

The global Prenatal Screening market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Prenatal Screening is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Prenatal Screening is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Prenatal Screening is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Prenatal Screening is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Prenatal Screening include Thermo Fisher Scientific, Revvity, Quest Diagnostics, MedGenome, Mayo Clinic Laboratories, GeneDx, PreventionGenetics, SYNLAB and Veritas Genetics, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Prenatal Screening, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Prenatal Screening, also provides the revenue of main regions and countries. Of the upcoming market potential for Prenatal Screening, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Prenatal Screening revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Prenatal Screening market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Prenatal Screening revenue, projected growth trends, production technology, application and end-user industry.

Prenatal Screening Segment by Company

Thermo Fisher Scientific

Revvity

Quest Diagnostics

MedGenome

Mayo Clinic Laboratories

GeneDx

PreventionGenetics

SYNLAB

Veritas Genetics

GGA

Cordlife

Rainbow Genomics

BGI Genomics

Berry Genomics

Annaroad

Jiajian Medical Testing

Genesky

Weihansi Biomedical Technology

Prenatal Screening Segment by Type

Serum Biomarker Screening

Ultrasonographic Imaging Screening

Others

Prenatal Screening Segment by Application

Public Hospitals

Private Hospitals

Prenatal Screening Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prenatal Screening market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prenatal Screening and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prenatal Screening.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Prenatal Screening in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Prenatal Screening company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Prenatal Screening revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Prenatal Screening Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Serum Biomarker Screening Major Player Table 3. Ultrasonographic Imaging Screening Major Player Table 4. Others Major Player Table 5. Global Prenatal Screening Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Public Hospitals Major Player Table 7. Private Hospitals Major Player Table 8. Prenatal Screening Industry Trends Table 9. Prenatal Screening Industry Drivers Table 10. Prenatal Screening Industry Opportunities and Challenges Table 11. Prenatal Screening Industry Restraints Table 12. Global Prenatal Screening Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Prenatal Screening Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Prenatal Screening Market Share by Region (2021-2026) Table 15. Global Prenatal Screening Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Prenatal Screening Market Share by Region (2027-2032) Table 17. Global Prenatal Screening Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Prenatal Screening Revenue Market Share by Players (2021-2026) Table 19. Global Prenatal Screening Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Prenatal Screening Key Players Headquarters & Area Served Table 21. Global Prenatal Screening Players, Product Type & Application Table 22. Global Prenatal Screening Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Prenatal Screening by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Prenatal Screening Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Prenatal Screening Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Prenatal Screening Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Prenatal Screening Revenue Market Share by Type (2021-2026) Table 29. Global Prenatal Screening Revenue Market Share by Type (2027-2032) Table 30. Global Prenatal Screening Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Prenatal Screening Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Prenatal Screening Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Prenatal Screening Revenue Market Share by Application (2021-2026) Table 34. Global Prenatal Screening Revenue Market Share by Application (2027-2032) Table 35. Thermo Fisher Scientific Company Information Table 36. Thermo Fisher Scientific Business Overview Table 37. Thermo Fisher Scientific Prenatal Screening Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Thermo Fisher Scientific Prenatal Screening Product Portfolio Table 39. Thermo Fisher Scientific Recent Development Table 40. Revvity Company Information Table 41. Revvity Business Overview Table 42. Revvity Prenatal Screening Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Revvity Prenatal Screening Product Portfolio Table 44. Revvity Recent Development Table 45. Quest Diagnostics Company Information Table 46. Quest Diagnostics Business Overview Table 47. Quest Diagnostics Prenatal Screening Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Quest Diagnostics Prenatal Screening Product Portfolio Table 49. Quest Diagnostics Recent Development Table 50. MedGenome Company Information Table 51. MedGenome Business Overview Table 52. MedGenome Prenatal Screening Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. MedGenome Prenatal Screening Product Portfolio Table 54. MedGenome Recent Development Table 55. Mayo Clinic Laboratories Company Information Table 56. Mayo Clinic Laboratories Business Overview Table 57. Mayo Clinic Laboratories Prenatal Screening Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Mayo Clinic Laboratories Prenatal Screening Product Portfolio Table 59. Mayo Clinic Laboratories Recent Development Table 60. GeneDx Company Information Table 61. GeneDx Business Overview Table 62. GeneDx Prenatal Screening Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. GeneDx Prenatal Screening Product Portfolio Table 64. GeneDx Recent Development Table 65. PreventionGenetics Company Information Table 66. PreventionGenetics Business Overview Table 67. PreventionGenetics Prenatal Screening Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. PreventionGenetics Prenatal Screening Product Portfolio Table 69. PreventionGenetics Recent Development Table 70. SYNLAB Company Information Table 71. SYNLAB Business Overview Table 72. SYNLAB Prenatal Screening Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. SYNLAB Prenatal Screening Product Portfolio Table 74. SYNLAB Recent Development Table 75. Veritas Genetics Company Information Table 76. Veritas Genetics Business Overview Table 77. Veritas Genetics Prenatal Screening Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Veritas Genetics Prenatal Screening Product Portfolio Table 79. Veritas Genetics Recent Development Table 80. GGA Company Information Table 81. GGA Business Overview Table 82. GGA Prenatal Screening Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. GGA Prenatal Screening Product Portfolio Table 84. GGA Recent Development Table 85. Cordlife Company Information Table 86. Cordlife Business Overview Table 87. Cordlife Prenatal Screening Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. Cordlife Prenatal Screening Product Portfolio Table 89. Cordlife Recent Development Table 90. Rainbow Genomics Company Information Table 91. Rainbow Genomics Business Overview Table 92. Rainbow Genomics Prenatal Screening Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Rainbow Genomics Prenatal Screening Product Portfolio Table 94. Rainbow Genomics Recent Development Table 95. BGI Genomics Company Information Table 96. BGI Genomics Business Overview Table 97. BGI Genomics Prenatal Screening Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. BGI Genomics Prenatal Screening Product Portfolio Table 99. BGI Genomics Recent Development Table 100. Berry Genomics Company Information Table 101. Berry Genomics Business Overview Table 102. Berry Genomics Prenatal Screening Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Berry Genomics Prenatal Screening Product Portfolio Table 104. Berry Genomics Recent Development Table 105. Annaroad Company Information Table 106. Annaroad Business Overview Table 107. Annaroad Prenatal Screening Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Annaroad Prenatal Screening Product Portfolio Table 109. Annaroad Recent Development Table 110. Jiajian Medical Testing Company Information Table 111. Jiajian Medical Testing Business Overview Table 112. Jiajian Medical Testing Prenatal Screening Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Jiajian Medical Testing Prenatal Screening Product Portfolio Table 114. Jiajian Medical Testing Recent Development Table 115. Genesky Company Information Table 116. Genesky Business Overview Table 117. Genesky Prenatal Screening Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Genesky Prenatal Screening Product Portfolio Table 119. Genesky Recent Development Table 120. Weihansi Biomedical Technology Company Information Table 121. Weihansi Biomedical Technology Business Overview Table 122. Weihansi Biomedical Technology Prenatal Screening Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Weihansi Biomedical Technology Prenatal Screening Product Portfolio Table 124. Weihansi Biomedical Technology Recent Development Table 125. North America Prenatal Screening Revenue by Type (2021-2026) & (US$ Million) Table 126. North America Prenatal Screening Revenue by Type (2027-2032) & (US$ Million) Table 127. North America Prenatal Screening Revenue by Application (2021-2026) & (US$ Million) Table 128. North America Prenatal Screening Revenue by Application (2027-2032) & (US$ Million) Table 129. North America Prenatal Screening Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. North America Prenatal Screening Revenue by Country (2021-2026) & (US$ Million) Table 131. North America Prenatal Screening Revenue by Country (US$ Million) & (2027-2032) Table 132. Europe Prenatal Screening Revenue by Type (2021-2026) & (US$ Million) Table 133. Europe Prenatal Screening Revenue by Type (2027-2032) & (US$ Million) Table 134. Europe Prenatal Screening Revenue by Application (2021-2026) & (US$ Million) Table 135. Europe Prenatal Screening Revenue by Application (2027-2032) & (US$ Million) Table 136. Europe Prenatal Screening Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. Europe Prenatal Screening Revenue by Country (2021-2026) & (US$ Million) Table 138. Europe Prenatal Screening Revenue by Country (US$ Million) & (2027-2032) Table 139. China Prenatal Screening Revenue by Type (2021-2026) & (US$ Million) Table 140. China Prenatal Screening Revenue by Type (2027-2032) & (US$ Million) Table 141. China Prenatal Screening Revenue by Application (2021-2026) & (US$ Million) Table 142. China Prenatal Screening Revenue by Application (2027-2032) & (US$ Million) Table 143. Asia Prenatal Screening Revenue by Type (2021-2026) & (US$ Million) Table 144. Asia Prenatal Screening Revenue by Type (2027-2032) & (US$ Million) Table 145. Asia Prenatal Screening Revenue by Application (2021-2026) & (US$ Million) Table 146. Asia Prenatal Screening Revenue by Application (2027-2032) & (US$ Million) Table 147. Asia Prenatal Screening Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 148. Asia Prenatal Screening Revenue by Region (US$ Million) & (2021-2026) Table 149. Asia Prenatal Screening Revenue by Region (US$ Million) & (2027-2032) Table 150. SAMEA Prenatal Screening Revenue by Type (2021-2026) & (US$ Million) Table 151. SAMEA Prenatal Screening Revenue by Type (2027-2032) & (US$ Million) Table 152. SAMEA Prenatal Screening Revenue by Application (2021-2026) & (US$ Million) Table 153. SAMEA Prenatal Screening Revenue by Application (2027-2032) & (US$ Million) Table 154. SAMEA Prenatal Screening Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 155. SAMEA Prenatal Screening Revenue by Country (2021-2026) & (US$ Million) Table 156. SAMEA Prenatal Screening Revenue by Country (US$ Million) & (2027-2032) Table 157. Research Programs/Design for This Report Table 158. Authors List of This Report Table 159. Secondary Sources Table 160. Primary Sources List of Figures Figure 1. Prenatal Screening Image Figure 2. Global Prenatal Screening Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Prenatal Screening Market Size Share 2021 VS 2025 VS 2032 Figure 4. Serum Biomarker Screening Image Figure 5. Ultrasonographic Imaging Screening Image Figure 6. Others Image Figure 7. Global Prenatal Screening Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Prenatal Screening Market Size Share 2021 VS 2025 VS 2032 Figure 9. Public Hospitals Image Figure 10. Private Hospitals Image Figure 11. Global Prenatal Screening Market Size (US$ Million) & (2021-2032) Figure 12. Global Prenatal Screening Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Prenatal Screening Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Prenatal Screening Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Prenatal Screening Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Prenatal Screening Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Prenatal Screening Revenue Market Share by Type (2021-2032) Figure 19. Global Prenatal Screening Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Prenatal Screening Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Prenatal Screening Revenue Market Share by Application (2021-2032) Figure 22. North America Prenatal Screening Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Prenatal Screening Revenue Share by Type (2021-2032) Figure 24. North America Prenatal Screening Revenue Share by Application (2021-2032) Figure 25. North America Prenatal Screening Revenue Share by Country (2021-2032) Figure 26. United States Prenatal Screening Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Prenatal Screening Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Prenatal Screening Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Prenatal Screening Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Prenatal Screening Revenue Share by Type (2021-2032) Figure 31. Europe Prenatal Screening Revenue Share by Application (2021-2032) Figure 32. Europe Prenatal Screening Revenue Share by Country (2021-2032) Figure 33. Germany Prenatal Screening Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Prenatal Screening Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Prenatal Screening Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Prenatal Screening Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Prenatal Screening Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Prenatal Screening Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Prenatal Screening Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Prenatal Screening Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Prenatal Screening Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Prenatal Screening Revenue Share by Type (2021-2032) Figure 43. China Prenatal Screening Revenue Share by Application (2021-2032) Figure 44. Asia Prenatal Screening Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Prenatal Screening Revenue Share by Type (2021-2032) Figure 46. Asia Prenatal Screening Revenue Share by Application (2021-2032) Figure 47. Asia Prenatal Screening Revenue Share by Region (2021-2032) Figure 48. Japan Prenatal Screening Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Prenatal Screening Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Prenatal Screening Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Prenatal Screening Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Prenatal Screening Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Prenatal Screening Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Prenatal Screening Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Prenatal Screening Revenue Share by Type (2021-2032) Figure 56. SAMEA Prenatal Screening Revenue Share by Application (2021-2032) Figure 57. SAMEA Prenatal Screening Revenue Share by Country (2021-2032) Figure 58. Brazil Prenatal Screening Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Prenatal Screening Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Prenatal Screening Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Prenatal Screening Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Prenatal Screening Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Prenatal Screening Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Prenatal Screening Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Prenatal Screening Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Prenatal Screening Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Prenatal Screening Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Prenatal Screening Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Serum Biomarker Screening
  • Ultrasonographic Imaging Screening
  • Others
Applications
  • Public Hospitals
  • Private Hospitals
Companies covered
  • Thermo Fisher Scientific
  • Revvity
  • Quest Diagnostics
  • MedGenome
  • Mayo Clinic Laboratories
  • GeneDx
  • PreventionGenetics
  • SYNLAB
  • Veritas Genetics
  • GGA
  • Cordlife
  • Rainbow Genomics
  • BGI Genomics
  • Berry Genomics
  • Annaroad
  • Jiajian Medical Testing
  • Genesky
  • Weihansi Biomedical Technology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Prenatal Screening Market by Type
  3. 1.2.1 Global Prenatal Screening Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Serum Biomarker Screening
  5. 1.2.3 Ultrasonographic Imaging Screening
  6. 1.2.4 Others
  7. 1.3 Prenatal Screening Market by Application
  8. 1.3.1 Global Prenatal Screening Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Public Hospitals
  10. 1.3.3 Private Hospitals
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Prenatal Screening Market Dynamics
  1. 2.1 Prenatal Screening Industry Trends
  2. 2.2 Prenatal Screening Industry Drivers
  3. 2.3 Prenatal Screening Industry Opportunities and Challenges
  4. 2.4 Prenatal Screening Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Prenatal Screening Market Perspective (2021-2032)
  2. 3.2 Global Prenatal Screening Growth Trends by Region
  3. 3.2.1 Global Prenatal Screening Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Prenatal Screening Market Size by Region (2021-2026)
  5. 3.2.3 Global Prenatal Screening Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Prenatal Screening Revenue by Players
  2. 4.1.1 Global Prenatal Screening Revenue by Players (2021-2026)
  3. 4.1.2 Global Prenatal Screening Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Prenatal Screening Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Prenatal Screening Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Prenatal Screening Key Players Headquarters & Area Served
  7. 4.4 Global Prenatal Screening Players, Product Type & Application
  8. 4.5 Global Prenatal Screening Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Prenatal Screening Market CR5 and HHI
  11. 4.6.3 2025 Prenatal Screening Tier 1, Tier 2, and Tier 3
5 Prenatal Screening Market Size by Type
  1. 5.1 Global Prenatal Screening Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Prenatal Screening Revenue by Type (2021-2032)
  3. 5.3 Global Prenatal Screening Revenue Market Share by Type (2021-2032)
6 Prenatal Screening Market Size by Application
  1. 6.1 Global Prenatal Screening Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Prenatal Screening Revenue by Application (2021-2032)
  3. 6.3 Global Prenatal Screening Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Thermo Fisher Scientific
  2. 7.1.1 Thermo Fisher Scientific Company Information
  3. 7.1.2 Thermo Fisher Scientific Business Overview
  4. 7.1.3 Thermo Fisher Scientific Prenatal Screening Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Thermo Fisher Scientific Prenatal Screening Product Portfolio
  6. 7.1.5 Thermo Fisher Scientific Recent Developments
  7. 7.2 Revvity
  8. 7.2.1 Revvity Company Information
  9. 7.2.2 Revvity Business Overview
  10. 7.2.3 Revvity Prenatal Screening Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Revvity Prenatal Screening Product Portfolio
  12. 7.2.5 Revvity Recent Developments
  13. 7.3 Quest Diagnostics
  14. 7.3.1 Quest Diagnostics Company Information
  15. 7.3.2 Quest Diagnostics Business Overview
  16. 7.3.3 Quest Diagnostics Prenatal Screening Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Quest Diagnostics Prenatal Screening Product Portfolio
  18. 7.3.5 Quest Diagnostics Recent Developments
  19. 7.4 MedGenome
  20. 7.4.1 MedGenome Company Information
  21. 7.4.2 MedGenome Business Overview
  22. 7.4.3 MedGenome Prenatal Screening Revenue and Gross Margin (2021-2026)
  23. 7.4.4 MedGenome Prenatal Screening Product Portfolio
  24. 7.4.5 MedGenome Recent Developments
  25. 7.5 Mayo Clinic Laboratories
  26. 7.5.1 Mayo Clinic Laboratories Company Information
  27. 7.5.2 Mayo Clinic Laboratories Business Overview
  28. 7.5.3 Mayo Clinic Laboratories Prenatal Screening Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Mayo Clinic Laboratories Prenatal Screening Product Portfolio
  30. 7.5.5 Mayo Clinic Laboratories Recent Developments
  31. 7.6 GeneDx
  32. 7.6.1 GeneDx Company Information
  33. 7.6.2 GeneDx Business Overview
  34. 7.6.3 GeneDx Prenatal Screening Revenue and Gross Margin (2021-2026)
  35. 7.6.4 GeneDx Prenatal Screening Product Portfolio
  36. 7.6.5 GeneDx Recent Developments
  37. 7.7 PreventionGenetics
  38. 7.7.1 PreventionGenetics Company Information
  39. 7.7.2 PreventionGenetics Business Overview
  40. 7.7.3 PreventionGenetics Prenatal Screening Revenue and Gross Margin (2021-2026)
  41. 7.7.4 PreventionGenetics Prenatal Screening Product Portfolio
  42. 7.7.5 PreventionGenetics Recent Developments
  43. 7.8 SYNLAB
  44. 7.8.1 SYNLAB Company Information
  45. 7.8.2 SYNLAB Business Overview
  46. 7.8.3 SYNLAB Prenatal Screening Revenue and Gross Margin (2021-2026)
  47. 7.8.4 SYNLAB Prenatal Screening Product Portfolio
  48. 7.8.5 SYNLAB Recent Developments
  49. 7.9 Veritas Genetics
  50. 7.9.1 Veritas Genetics Company Information
  51. 7.9.2 Veritas Genetics Business Overview
  52. 7.9.3 Veritas Genetics Prenatal Screening Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Veritas Genetics Prenatal Screening Product Portfolio
  54. 7.9.5 Veritas Genetics Recent Developments
  55. 7.10 GGA
  56. 7.10.1 GGA Company Information
  57. 7.10.2 GGA Business Overview
  58. 7.10.3 GGA Prenatal Screening Revenue and Gross Margin (2021-2026)
  59. 7.10.4 GGA Prenatal Screening Product Portfolio
  60. 7.10.5 GGA Recent Developments
  61. 7.11 Cordlife
  62. 7.11.1 Cordlife Company Information
  63. 7.11.2 Cordlife Business Overview
  64. 7.11.3 Cordlife Prenatal Screening Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Cordlife Prenatal Screening Product Portfolio
  66. 7.11.5 Cordlife Recent Developments
  67. 7.12 Rainbow Genomics
  68. 7.12.1 Rainbow Genomics Company Information
  69. 7.12.2 Rainbow Genomics Business Overview
  70. 7.12.3 Rainbow Genomics Prenatal Screening Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Rainbow Genomics Prenatal Screening Product Portfolio
  72. 7.12.5 Rainbow Genomics Recent Developments
  73. 7.13 BGI Genomics
  74. 7.13.1 BGI Genomics Company Information
  75. 7.13.2 BGI Genomics Business Overview
  76. 7.13.3 BGI Genomics Prenatal Screening Revenue and Gross Margin (2021-2026)
  77. 7.13.4 BGI Genomics Prenatal Screening Product Portfolio
  78. 7.13.5 BGI Genomics Recent Developments
  79. 7.14 Berry Genomics
  80. 7.14.1 Berry Genomics Company Information
  81. 7.14.2 Berry Genomics Business Overview
  82. 7.14.3 Berry Genomics Prenatal Screening Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Berry Genomics Prenatal Screening Product Portfolio
  84. 7.14.5 Berry Genomics Recent Developments
  85. 7.15 Annaroad
  86. 7.15.1 Annaroad Company Information
  87. 7.15.2 Annaroad Business Overview
  88. 7.15.3 Annaroad Prenatal Screening Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Annaroad Prenatal Screening Product Portfolio
  90. 7.15.5 Annaroad Recent Developments
  91. 7.16 Jiajian Medical Testing
  92. 7.16.1 Jiajian Medical Testing Company Information
  93. 7.16.2 Jiajian Medical Testing Business Overview
  94. 7.16.3 Jiajian Medical Testing Prenatal Screening Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Jiajian Medical Testing Prenatal Screening Product Portfolio
  96. 7.16.5 Jiajian Medical Testing Recent Developments
  97. 7.17 Genesky
  98. 7.17.1 Genesky Company Information
  99. 7.17.2 Genesky Business Overview
  100. 7.17.3 Genesky Prenatal Screening Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Genesky Prenatal Screening Product Portfolio
  102. 7.17.5 Genesky Recent Developments
  103. 7.18 Weihansi Biomedical Technology
  104. 7.18.1 Weihansi Biomedical Technology Company Information
  105. 7.18.2 Weihansi Biomedical Technology Business Overview
  106. 7.18.3 Weihansi Biomedical Technology Prenatal Screening Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Weihansi Biomedical Technology Prenatal Screening Product Portfolio
  108. 7.18.5 Weihansi Biomedical Technology Recent Developments
8 North America
  1. 8.1 North America Prenatal Screening Revenue (2021-2032)
  2. 8.2 North America Prenatal Screening Revenue by Type (2021-2032)
  3. 8.2.1 North America Prenatal Screening Revenue by Type (2021-2026)
  4. 8.2.2 North America Prenatal Screening Revenue by Type (2027-2032)
  5. 8.3 North America Prenatal Screening Revenue Share by Type (2021-2032)
  6. 8.4 North America Prenatal Screening Revenue by Application (2021-2032)
  7. 8.4.1 North America Prenatal Screening Revenue by Application (2021-2026)
  8. 8.4.2 North America Prenatal Screening Revenue by Application (2027-2032)
  9. 8.5 North America Prenatal Screening Revenue Share by Application (2021-2032)
  10. 8.6 North America Prenatal Screening Revenue by Country
  11. 8.6.1 North America Prenatal Screening Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Prenatal Screening Revenue by Country (2021-2026)
  13. 8.6.3 North America Prenatal Screening Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Prenatal Screening Revenue (2021-2032)
  2. 9.2 Europe Prenatal Screening Revenue by Type (2021-2032)
  3. 9.2.1 Europe Prenatal Screening Revenue by Type (2021-2026)
  4. 9.2.2 Europe Prenatal Screening Revenue by Type (2027-2032)
  5. 9.3 Europe Prenatal Screening Revenue Share by Type (2021-2032)
  6. 9.4 Europe Prenatal Screening Revenue by Application (2021-2032)
  7. 9.4.1 Europe Prenatal Screening Revenue by Application (2021-2026)
  8. 9.4.2 Europe Prenatal Screening Revenue by Application (2027-2032)
  9. 9.5 Europe Prenatal Screening Revenue Share by Application (2021-2032)
  10. 9.6 Europe Prenatal Screening Revenue by Country
  11. 9.6.1 Europe Prenatal Screening Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Prenatal Screening Revenue by Country (2021-2026)
  13. 9.6.3 Europe Prenatal Screening Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Prenatal Screening Revenue (2021-2032)
  2. 10.2 China Prenatal Screening Revenue by Type (2021-2032)
  3. 10.2.1 China Prenatal Screening Revenue by Type (2021-2026)
  4. 10.2.2 China Prenatal Screening Revenue by Type (2027-2032)
  5. 10.3 China Prenatal Screening Revenue Share by Type (2021-2032)
  6. 10.4 China Prenatal Screening Revenue by Application (2021-2032)
  7. 10.4.1 China Prenatal Screening Revenue by Application (2021-2026)
  8. 10.4.2 China Prenatal Screening Revenue by Application (2027-2032)
  9. 10.5 China Prenatal Screening Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Prenatal Screening Revenue (2021-2032)
  2. 11.2 Asia Prenatal Screening Revenue by Type (2021-2032)
  3. 11.2.1 Asia Prenatal Screening Revenue by Type (2021-2026)
  4. 11.2.2 Asia Prenatal Screening Revenue by Type (2027-2032)
  5. 11.3 Asia Prenatal Screening Revenue Share by Type (2021-2032)
  6. 11.4 Asia Prenatal Screening Revenue by Application (2021-2032)
  7. 11.4.1 Asia Prenatal Screening Revenue by Application (2021-2026)
  8. 11.4.2 Asia Prenatal Screening Revenue by Application (2027-2032)
  9. 11.5 Asia Prenatal Screening Revenue Share by Application (2021-2032)
  10. 11.6 Asia Prenatal Screening Revenue by Country
  11. 11.6.1 Asia Prenatal Screening Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Prenatal Screening Revenue by Country (2021-2026)
  13. 11.6.3 Asia Prenatal Screening Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Prenatal Screening Revenue (2021-2032)
  2. 12.2 SAMEA Prenatal Screening Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Prenatal Screening Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Prenatal Screening Revenue by Type (2027-2032)
  5. 12.3 SAMEA Prenatal Screening Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Prenatal Screening Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Prenatal Screening Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Prenatal Screening Revenue by Application (2027-2032)
  9. 12.5 SAMEA Prenatal Screening Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Prenatal Screening Revenue by Country
  11. 12.6.1 SAMEA Prenatal Screening Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Prenatal Screening Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Prenatal Screening Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst